DARE - Company ID 0001401914
Dare Bioscience, Inc. (DARE) reported net income of -$13.40M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$13.40M | -230.9% |
| FY 2024 | -$4.05M | +86.6% |
| FY 2023 | -$30.16M | +2.5% |
| FY 2022 | -$30.95M | +20.0% |
| FY 2021 | -$38.70M | -41.2% |
| FY 2020 | -$27.40M | -92.1% |
| FY 2019 | -$14.26M | +14.8% |
| FY 2018 | -$16.74M | -45.5% |
| FY 2017 |
Dare Bioscience, Inc. (DARE) reported net income of -$13.40M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2012 and fiscal 2025, Dare Bioscience, Inc.'s net income grew from -$22.10M to -$13.40M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$11.50M |
| -1610.0% |
| FY 2016 | -$672.69K | +98.3% |
| FY 2015 | -$39.59M | -69.6% |
| FY 2014 | -$23.34M | -36.2% |
| FY 2013 | -$17.14M | +22.4% |
| FY 2012 | -$22.10M | - |